Skip to main content
Clinical Trials/ACTRN12616000519459
ACTRN12616000519459
Not yet recruiting
未知

Assessing Predictive and Prognostic Biomarkers in Pancreatic Cancer

The Walter and Eliza Hall Institute of Medical Research0 sites500 target enrollmentApril 21, 2016

Overview

Phase
未知
Intervention
Not specified
Conditions
Histologically or cytologically confirmed pancreatic cancer
Sponsor
The Walter and Eliza Hall Institute of Medical Research
Enrollment
500
Status
Not yet recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 21, 2016
End Date
TBD
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Male and female
  • 2\. At least 18 years of age
  • 3\. Patients with histologically or cytologically confirmed pancreatic cancer.
  • 4\. Able to provide archival tumour specimen for molecular analysis
  • 5\. Accessible for follow up and data collection
  • 6\. Able and willing to provide informed consent for any blood and urine collection above standard of care. Able to provide written, voluntary and informed consent for blood and/or urine collection

Exclusion Criteria

  • 1\. No archival tissue specimen available for molecular analysis
  • 2\. Medical or psychiatric condition or occupational responsibilities that may preclude compliance with the tissue collection protocol
  • 3\. Females who are pregnant

Outcomes

Primary Outcomes

Not specified

Similar Trials